emeis (EMEIS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
30 Jul, 2026Business overview and market trends
Operates over 1,000 facilities with 94,500 beds across 21 countries, generating €2.9bn revenue in H1 2025, up 6.2% organically.
Core activities include nursing homes (65% of revenue), clinics (30%), and mental health services, with a strong European focus.
Demographic trends, such as a growing senior population and rising chronic illness, drive long-term demand, with a projected 30% increase in seniors over 75 in Europe within 10 years.
Significant supply shortfall in nursing home beds expected, with 800,000 new beds needed by 2035 in key European markets.
High barriers to entry due to regulatory constraints and licensing requirements across main geographies.
Operational recovery and performance
Customer satisfaction rates rose to 93% in 2024, with NPS improving to 37; quality of care and operational standards enhanced.
Occupancy rates increased by 1.8 points year-on-year to 88% in Q3 2025, with nursing homes reaching 87% and clinics also improving.
Revenue reached €2,908m in H1 2025 (+6.2% organic), EBITDAR €401m (+20% LfL), and EBITDA €158m (+79% LfL).
Operating margins and cash flow improved, with free cash flow turning positive at €26m in H1 2025.
Staff turnover and absenteeism rates declined, and operational expenses were kept under control, supporting margin recovery.
Financial structure and disposals
Over €2.4bn in asset disposals achieved or secured since mid-2022, exceeding the €1.5bn target, with further deals pending.
Net debt (excl. IFRS 16 & 5) decreased by €233m in H1 2025, with a further reduction of €700m expected from a new real estate partnership.
Leverage ratio improved from 19.5x at end-2024 to 15.4x in H1 2025, with a proforma target of 13.1x after real estate transactions.
Full refinancing of bank exposure completed with €3.15bn new debt, extending average maturity to 5 years and reshaping the debt profile.
Capital structure now features a stable, mission-aligned shareholder base and strengthened governance.
Latest events from emeis
- H1 2026 saw 6% revenue growth, margin expansion, debt reduction, and upgraded EBITDAR guidance.EMEIS
Q2 2026 TU30 Jul 2026 - Strong organic growth, margin expansion, disposals above target, and leverage improvement.EMEIS
H1 20259 Jul 2026 - 2025 delivered robust growth, margin expansion, and €1bn net debt reduction, with a positive outlook.EMEIS
H2 20258 Jul 2026 - Revenue up 9.2%, net loss narrows, and debt falls after major restructuring.EMEIS
H1 202426 Jun 2026 - Q1 2026 delivered 6.3% organic revenue growth and occupancy rates of 89.1%.EMEIS
Q1 2026 TU7 May 2026 - 2025 saw robust growth, margin recovery, and major deleveraging, exceeding guidance.EMEIS
Q4 2025 TU17 Apr 2026 - 2024 results beat guidance with strong margin recovery and €916m in asset disposals.EMEIS
Q4 2024 TU29 Dec 2025 - EBITDAR and EBITDA exceeded guidance as revenue, margins, and occupancy improved in 2024.EMEIS
H2 202425 Dec 2025 - Q3 2025 saw strong organic growth, high occupancy, and a positive outlook for 2025.EMEIS
Q3 2025 TU10 Dec 2025